These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27000145)

  • 21. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.
    Whitfield THF; John SA; Rendina HJ; Grov C; Parsons JT
    AIDS Behav; 2018 Nov; 22(11):3566-3575. PubMed ID: 29404756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
    Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
    AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men.
    Holt M; Murphy DA; Callander D; Ellard J; Rosengarten M; Kippax SC; de Wit JB
    Sex Transm Infect; 2012 Jun; 88(4):258-63. PubMed ID: 22290327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
    Cole SW; Glick JL; Campoamor NB; Sanchez TH; Sarkar S; Vannappagari V; Rinehart A; Rawlings K; Sullivan PS; Bridges JFP
    BMJ Open; 2024 Apr; 14(4):e083837. PubMed ID: 38653510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
    Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
    J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prepared for PrEP: preferences for HIV pre-exposure prophylaxis among Chinese men who have sex with men in an online national survey.
    Huang W; Wu D; Ong JJ; Smith MK; Pan S; Yang F; Fu H; Tang W; Tucker JD
    BMC Infect Dis; 2019 Dec; 19(1):1057. PubMed ID: 31842772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.
    Meyers K; Wu Y; Brill A; Sandfort T; Golub SA
    PLoS One; 2018; 13(7):e0200296. PubMed ID: 30024903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
    Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
    BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: implications for biomedical HIV prevention.
    Young I; Li J; McDaid L
    PLoS One; 2013; 8(5):e64038. PubMed ID: 23691143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
    Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
    Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women's Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States.
    Philbin MM; Parish C; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
    AIDS Behav; 2021 Mar; 25(3):667-678. PubMed ID: 32910351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness of Pre-exposure Prophylaxis for HIV, Willingness to Use It and Potential Barriers or Facilitators to Uptake Among Men Who Have Sex with Men in Spain.
    Ferrer L; Folch C; Fernandez-Davila P; Garcia A; Morales A; Belda J; Susperregui AR; Casabona J;
    AIDS Behav; 2016 Jul; 20(7):1423-33. PubMed ID: 27022938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness and Acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya.
    Ogunbajo A; Kang A; Shangani S; Wade RM; Onyango DP; Odero WW; Harper GW
    AIDS Care; 2019 Oct; 31(10):1185-1192. PubMed ID: 31039628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.
    Wang H; Zimmermann HML; van de Vijver D; Jonas KJ
    AIDS Care; 2024 Jul; 36(sup1):89-100. PubMed ID: 38713631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Willingness to use HIV pre-exposure prophylaxis has declined among australian gay and bisexual men: results from repeated national surveys, 2011-2013.
    Holt M; Lea T; Murphy D; Ellard J; Rosengarten M; Kippax S; De Wit J
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):222-6. PubMed ID: 25078535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Pre-exposure Prophylaxis (PrEP) Uptake Among Gay and Bisexual Men in Australia and Factors Associated With the Nonuse of PrEP Among Eligible Men: Results From a Prospective Cohort Study.
    Hammoud MA; Vaccher S; Jin F; Bourne A; Maher L; Holt M; Bavinton BR; Haire B; Degenhardt L; Grulich A; Prestage GP
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e73-e84. PubMed ID: 30973548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
    Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
    Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighing the Options: Which PrEP (Pre-exposure Prophylaxis) Modality Attributes Influence Choice for Young Gay and Bisexual Men in the United States?
    Hill-Rorie J; Biello KB; Quint M; Johnson B; Elopre L; Johnson K; Lillis R; Burgan K; Krakower D; Whiteside Y; Mayer KH
    AIDS Behav; 2024 Sep; 28(9):2970-2978. PubMed ID: 39126557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.